메뉴 건너뛰기




Volumn 129, Issue 23, 2004, Pages 1328-1334

Spondyloarthritides - Classification, diagnostic procedures and therapy;Spondyloarthritiden - Neue aspekte zur klassifikation, diagnostik und therapie

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2 INHIBITOR; ETANERCEPT; GLUCOCORTICOID; INDOMETACIN; INFLIXIMAB; PAMIDRONIC ACID; SALAZOSULFAPYRIDINE; STEROID;

EID: 3042632323     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-826869     Document Type: Review
Times cited : (2)

References (49)
  • 1
    • 0028881591 scopus 로고
    • Management of refractory ankylosing spondylitis and related spondylarthropathies
    • Amor B, Dougados M, Khan MA. Management of refractory ankylosing spondylitis and related spondylarthropathies. Rheum Dis Clin North Am 1995; 21: 117-128
    • (1995) Rheum Dis Clin North Am , vol.21 , pp. 117-128
    • Amor, B.1    Dougados, M.2    Khan, M.A.3
  • 3
    • 0036558995 scopus 로고    scopus 로고
    • Confidence in the diagnosis of early spondylarthropathy
    • Berthelot JM, Saraux A, Le Henaff C et al. Confidence in the diagnosis of early spondylarthropathy. Clin Exp Rheumatol 2002; 20: 319-326
    • (2002) Clin Exp Rheumatol , vol.20 , pp. 319-326
    • Berthelot, J.M.1    Saraux, A.2    Le Henaff, C.3
  • 4
    • 0242526924 scopus 로고    scopus 로고
    • Die Akzeptanz des Schulungsprogramms der DGRh für Patienten mit Spondylitis ankylosans und verwandten Spondylarthropathien
    • Bönisch A, Ehlebracht-Kömg I. Die Akzeptanz des Schulungsprogramms der DGRh für Patienten mit Spondylitis ankylosans und verwandten Spondylarthropathien. Akt Rheumatol 2003; 28: 254-263
    • (2003) Akt Rheumatol , vol.28 , pp. 254-263
    • Bönisch, A.1    Ehlebracht-Kömg, I.2
  • 5
    • 0032726541 scopus 로고    scopus 로고
    • Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging
    • Brandt J, Bollow M, Haberle J et al. Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging. Rheumatology 1999; 38: 831-836
    • (1999) Rheumatology , vol.38 , pp. 831-836
    • Brandt, J.1    Bollow, M.2    Haberle, J.3
  • 6
    • 0037783485 scopus 로고    scopus 로고
    • Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis
    • Brandt J, Khariouzov A, Listing J et al. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 2003; 48: 1667-1675
    • (2003) Arthritis Rheum , vol.48 , pp. 1667-1675
    • Brandt, J.1    Khariouzov, A.2    Listing, J.3
  • 7
    • 0029926665 scopus 로고    scopus 로고
    • Computed tomography guided injection of sacroiliac joint in patients with spondylarthropathy with sacroiliitis
    • Braun J et al. Computed tomography guided injection of sacroiliac joint in patients with spondylarthropathy with sacroiliitis. J Rheumatol 1996; 23: 659-664
    • (1996) J Rheumatol , vol.23 , pp. 659-664
    • Braun, J.1
  • 8
    • 0031972623 scopus 로고    scopus 로고
    • Prevalence of spondylarthropathies in HLA-B27 positive and negative mood donors
    • Braun J, Bollow M, Remlinger C et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative mood donors. Arthritis Rheum 1998; 41: 58-67
    • (1998) Arthritis Rheum , vol.41 , pp. 58-67
    • Braun, J.1    Bollow, M.2    Remlinger, C.3
  • 11
    • 0037029430 scopus 로고    scopus 로고
    • Treatment of active ankylosing spondylitis with infliximab: A randomised controlled multicentre trial
    • Braun J, Brandt J, Listing J et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002; 359: 1187-1193
    • (2002) Lancet , vol.359 , pp. 1187-1193
    • Braun, J.1    Brandt, J.2    Listing, J.3
  • 12
    • 0038423033 scopus 로고    scopus 로고
    • International ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
    • Braun J, Pham T, Sieper J, van der Linden S, Dougados M, van der Heijde D for the ASAS working group. International ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003; 62: 817-824
    • (2003) Ann Rheum Dis , vol.62 , pp. 817-824
    • Braun, J.1    Pham, T.2    Sieper, J.3    Van Der Linden, S.4    Dougados, M.5    Van Der Heijde, D.6
  • 13
    • 0042072982 scopus 로고    scopus 로고
    • Long term efficacy and safety of infliximab in the treatment of ankylosing spondylitis
    • Braun J, Brandt J, Listing J et al. Long term efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Arthritis Rheum 2003; 48: 2224-2233
    • (2003) Arthritis Rheum , vol.48 , pp. 2224-2233
    • Braun, J.1    Brandt, J.2    Listing, J.3
  • 14
    • 0033511186 scopus 로고    scopus 로고
    • Comparison of sulphasalazine and placebo for the treatment of axial and peripheral articular manifestations of seronegative spondylarthropathies
    • Clegg DO, Reda DJ, Abdellatif M. Comparison of sulphasalazine and placebo for the treatment of axial and peripheral articular manifestations of seronegative spondylarthropathies. Arthritis Rheum 1999; 42: 2325-2329
    • (1999) Arthritis Rheum , vol.42 , pp. 2325-2329
    • Clegg, D.O.1    Reda, D.J.2    Abdellatif, M.3
  • 15
    • 0034538715 scopus 로고    scopus 로고
    • Can some cases of 'possible' Spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy?
    • Collantes E, Veroz R, Escudero A the Spanish Spondyloarthropathy Study Group. Can some cases of 'possible' Spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Joint Bone Spine 2000; 67: 516-520
    • (2000) Joint Bone Spine , vol.67 , pp. 516-520
    • Collantes, E.1    Veroz, R.2    Escudero, A.3
  • 16
    • 0026003027 scopus 로고
    • Preliminary criteria for the classification of spondylarthropathy
    • The European Spondylarthropathy Study Group
    • Dougados M, van der Linden SM, Jhulin R et al. The European Spondylarthropathy Study Group. Preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218-1227
    • (1991) Arthritis Rheum , vol.34 , pp. 1218-1227
    • Dougados, M.1    Van Der Linden, S.M.2    Jhulin, R.3
  • 18
    • 0035150435 scopus 로고    scopus 로고
    • Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis
    • Dougados M, Behier JM, Jolcine I et al. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis. Arthritis Rheum 2001; 44: 80-85
    • (2001) Arthritis Rheum , vol.44 , pp. 80-85
    • Dougados, M.1    Behier, J.M.2    Jolcine, I.3
  • 19
    • 84862356254 scopus 로고    scopus 로고
    • Bewertung eines Schulungsprogramms für Patienten mit Spondylitis ankylosans
    • Ehlebracht-König I. Bewertung eines Schulungsprogramms für Patienten mit Spondylitis ankylosans. Bechterew-Brief 2003; 92: 3-12
    • (2003) Bechterew-Brief , vol.92 , pp. 3-12
    • Ehlebracht-König, I.1
  • 20
    • 0242443383 scopus 로고    scopus 로고
    • Das Schulungsprogramm der DGRh für Patienten mit Spondylitis ankylosans und verwandten Spondylarthropathien - Programmaufbau
    • Ehlebracht-König I, Bönisch A. Das Schulungsprogramm der DGRh für Patienten mit Spondylitis ankylosans und verwandten Spondylarthropathien - Programmaufbau. Akt Rheumatol 2003; 28: 243-253
    • (2003) Akt Rheumatol , vol.28 , pp. 243-253
    • Ehlebracht-König, I.1    Bönisch, A.2
  • 21
    • 0028575453 scopus 로고
    • A new approach to defining disease status in ankylosing spondylitis
    • Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis. J Rheumatol 1994; 21: 2286-2291
    • (1994) J Rheumatol , vol.21 , pp. 2286-2291
    • Garrett, S.1    Jenkinson, T.2    Kennedy, L.G.3
  • 22
    • 0037007683 scopus 로고    scopus 로고
    • Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha
    • Gorman JD, Sack KE, Jr. Davis JC. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002; 346: 1349-1356
    • (2002) N Engl J Med , vol.346 , pp. 1349-1356
    • Gorman, J.D.1    Sack Jr., K.E.2    Davis, J.C.3
  • 24
    • 0027296402 scopus 로고
    • The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years
    • Kirwan J, Edwards A, Huitfeldt B, Thompson P, Currey H. The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years. Br J Rheumatol 1993; 32: 729-733
    • (1993) Br J Rheumatol , vol.32 , pp. 729-733
    • Kirwan, J.1    Edwards, A.2    Huitfeldt, B.3    Thompson, P.4    Currey, H.5
  • 26
    • 0141560728 scopus 로고    scopus 로고
    • Rational for the use of Cyclooxygenase-2 specific nonsteroidal antiinflammatory drugs in ankylosing spondylitis - Which evidences are available?
    • Koehler L, Kuipers JG, Zeidler H. Rational for the use of Cyclooxygenase-2 specific nonsteroidal antiinflammatory drugs in ankylosing spondylitis - Which evidences are available? Curr Rheumatol Rep 2003; 5: 178-180
    • (2003) Curr Rheumatol Rep , vol.5 , pp. 178-180
    • Koehler, L.1    Kuipers, J.G.2    Zeidler, H.3
  • 27
    • 0034890083 scopus 로고    scopus 로고
    • Long-term outcome of undifferentiated spondylarthropathy
    • Kumar A, Bansal M, Srivastava DN et al. Long-term outcome of undifferentiated spondylarthropathy. Rheumatol Intern 2001; 20: 221-224
    • (2001) Rheumatol Intern , vol.20 , pp. 221-224
    • Kumar, A.1    Bansal, M.2    Srivastava, D.N.3
  • 28
    • 0029617257 scopus 로고
    • Persistence of enthesopathic changes in patients with spondylarthropathy during a 6-month follow-up
    • Lethinen A, Leirisalo-Repo M, Taavitsainen M. Persistence of enthesopathic changes in patients with spondylarthropathy during a 6-month follow-up. Clin Exp Rheumatol 1995; 13: 733-736
    • (1995) Clin Exp Rheumatol , vol.13 , pp. 733-736
    • Lethinen, A.1    Leirisalo-Repo, M.2    Taavitsainen, M.3
  • 29
    • 0036188770 scopus 로고    scopus 로고
    • A six-month randomized, controlled, double-blinded, dose response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of NSAID-refractory ankylosing spondylitis
    • Maksymowych WP, Jhangri GS, Fitzgerald A et al. A six-month randomized, controlled, double-blinded, dose response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of NSAID-refractory ankylosing spondylitis. Arthritis Rheum 2002; 46: 766-782
    • (2002) Arthritis Rheum , vol.46 , pp. 766-782
    • Maksymowych, W.P.1    Jhangri, G.S.2    Fitzgerald, A.3
  • 30
    • 0035459313 scopus 로고    scopus 로고
    • Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy
    • Marzo-Ortega H et al. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy. Arthritis Rheum 2001; 44: 2112-2117
    • (2001) Arthritis Rheum , vol.44 , pp. 2112-2117
    • Marzo-Ortega, H.1
  • 31
    • 0023719950 scopus 로고
    • Clinical features and prognosis of patients with possible ankylosing spondylitis
    • Mau W, Zeidler H, Mau R et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. J Rheumatol 1988; 15: 1109-1114
    • (1988) J Rheumatol , vol.15 , pp. 1109-1114
    • Mau, W.1    Zeidler, H.2    Mau, R.3
  • 32
    • 0029765115 scopus 로고    scopus 로고
    • Assessment of the efficacy of sacroiliac corticoid injections in spondylarthropathies
    • Maugars Y, Mathis C et al. Assessment of the efficacy of sacroiliac corticoid injections in spondylarthropathies. Br J Rheumatol 1996; 35: 767-770
    • (1996) Br J Rheumatol , vol.35 , pp. 767-770
    • Maugars, Y.1    Mathis, C.2
  • 33
    • 0031765693 scopus 로고    scopus 로고
    • Enthesiopathy: Clinical manifestations, imaging and treatment
    • Olivieri I, Barozzi L, Padula A. Enthesiopathy: clinical manifestations, imaging and treatment. Baillieres Clin Rheumatol 1998; 12: 665-681
    • (1998) Baillieres Clin Rheumatol , vol.12 , pp. 665-681
    • Olivieri, I.1    Barozzi, L.2    Padula, A.3
  • 34
    • 0034840543 scopus 로고    scopus 로고
    • Ankylosing spondylitis and undifferentiated spondyloarthropathies
    • Olivieri I, Salvarani C, Cantine F et al. Ankylosing spondylitis and undifferentiated spondyloarthropathies. Curr Opin Rheumatol 2001; 13: 280-284
    • (2001) Curr Opin Rheumatol , vol.13 , pp. 280-284
    • Olivieri, I.1    Salvarani, C.2    Cantine, F.3
  • 36
    • 1942436201 scopus 로고    scopus 로고
    • How to diagnose axial spondyloarthritis early?
    • Rudwaleit M, van der Heijde D, Khan M et al. How to diagnose axial spondyloarthritis early? Ann Rheum Dis 2004; 63: 535-543
    • (2004) Ann Rheum Dis , vol.63 , pp. 535-543
    • Rudwaleit, M.1    Van Der Heijde, D.2    Khan, M.3
  • 37
    • 0001736719 scopus 로고
    • Spondylitis ankylopoetica:Die so genannte Bechterewsche Krankheit und ihre Differentialdiagnose
    • Berlin, Heidelberg, New York, Tokio, Springer, Diethelm L (Hrsg)
    • Schilling F. Spondylitis ankylopoetica:Die so genannte Bechterewsche Krankheit und ihre Differentialdiagnose. Berlin, Heidelberg, New York, Tokio, Springer, In: Diethelm L (Hrsg) Handbuch der medizinischen Radiologie. 1974: 452-689
    • (1974) Handbuch der Medizinischen Radiologie , pp. 452-689
    • Schilling, F.1
  • 39
    • 0032915527 scopus 로고    scopus 로고
    • Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis
    • Spoorenberg A, van der Heijde D, de Klerk E et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999; 26: 980-984
    • (1999) J Rheumatol , vol.26 , pp. 980-984
    • Spoorenberg, A.1    Van Der Heijde, D.2    De Klerk, E.3
  • 40
    • 0031818027 scopus 로고    scopus 로고
    • Current guidelines for drug treatment of ankylosing spondylitis
    • Toussirot E, Wendling D. Current guidelines for drug treatment of ankylosing spondylitis. Drugs 1998; 5: 225-240
    • (1998) Drugs , vol.5 , pp. 225-240
    • Toussirot, E.1    Wendling, D.2
  • 41
    • 0029616525 scopus 로고
    • Inflammatory back pain in primary care
    • Underwood MR, Dawes P. Inflammatory back pain in primary care. Br J Rheumatol 1995; 34: 1074-1077
    • (1995) Br J Rheumatol , vol.34 , pp. 1074-1077
    • Underwood, M.R.1    Dawes, P.2
  • 42
    • 0036188187 scopus 로고    scopus 로고
    • Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy
    • van den Bosch F, Kruithof E, Baeten D et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. Arthritis Rheum 2002; 46: 755-765
    • (2002) Arthritis Rheum , vol.46 , pp. 755-765
    • Van Den Bosch, F.1    Kruithof, E.2    Baeten, D.3
  • 43
    • 0021272107 scopus 로고
    • Evaluation of diagnostic criteria for ankylosing spondylitis
    • van der Linden SM, Valkeburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum 1984; 27: 361-368
    • (1984) Arthritis Rheum , vol.27 , pp. 361-368
    • Van Der Linden, S.M.1    Valkeburg, H.A.2    Cats, A.3
  • 44
    • 0034758237 scopus 로고    scopus 로고
    • Combined spa-exercise therapy is effective in patients with ankylosing spondylitis
    • van Tubergen A et al. Combined spa-exercise therapy is effective in patients with ankylosing spondylitis. Arthritis Rheum 2001; 45: 430-438
    • (2001) Arthritis Rheum , vol.45 , pp. 430-438
    • Van Tubergen, A.1
  • 45
    • 0037109238 scopus 로고    scopus 로고
    • Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis
    • van Tubergen A, Boonen A, Landewe R et al. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis. Arthritis Rheum 2002; 47: 459-467
    • (2002) Arthritis Rheum , vol.47 , pp. 459-467
    • Van Tubergen, A.1    Boonen, A.2    Landewe, R.3
  • 46
    • 1642472317 scopus 로고    scopus 로고
    • Inhibition of radiographic progression in ankylosing spondylitis (AS) by continuous use of NSAIDS
    • Wanders A. Inhibition of radiographic progression in ankylosing spondylitis (AS) by continuous use of NSAIDS. Arthritis Rheum 2003; 48 (Suppl): S 233
    • (2003) Arthritis Rheum , vol.48 , Issue.SUPPL.
    • Wanders, A.1
  • 48
    • 0034020245 scopus 로고    scopus 로고
    • Disability and handicap in rheumatoid arthritis and ankylosing spondylitis - Results from the German rheumatological database
    • German Collaborative Arthritis Centers
    • Zink A, Braun J, Listin J, Wollenhaupt J. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis - results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 2000; 27: 613-622
    • (2000) J Rheumatol , vol.27 , pp. 613-622
    • Zink, A.1    Braun, J.2    Listin, J.3    Wollenhaupt, J.4
  • 49
    • 4244054230 scopus 로고    scopus 로고
    • Local radiotherapy for painful heels with spondarthropathies
    • 2nd edn (Hrsg). London, Mosby, Klippel JH, Dieppe PA (eds.).
    • Zvaifler NJ, Seagren SL. Local radiotherapy for painful heels with spondarthropathies. 2nd edn (Hrsg). London, Mosby, In: Klippel JH, Dieppe PA (eds.). Rheumatology. 1998; Vol 2: 20.7-20.8.
    • (1998) Rheumatology , vol.2 , pp. 207-208
    • Zvaifler, N.J.1    Seagren, S.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.